BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19226329)

  • 1. The HCV serum proteome: a search for fibrosis protein markers.
    Cheung KJ; Tilleman K; Deforce D; Colle I; Van Vlierberghe H
    J Viral Hepat; 2009 Jun; 16(6):418-29. PubMed ID: 19226329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of a novel serum proteome-derived index FI-PRO (fibrosis-protein) in the prediction of fibrosis in chronic hepatitis C.
    Cheung KJ; Tilleman K; Deforce D; Colle I; Moreno C; Gustot T; Van Vlierberghe H
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):701-10. PubMed ID: 21623191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndecan 1 (CD138) serum levels: a novel biomarker in predicting liver fibrosis stage in patients with hepatitis C.
    Zvibel I; Halfon P; Fishman S; Penaranda G; Leshno M; Or AB; Halpern Z; Oren R
    Liver Int; 2009 Feb; 29(2):208-12. PubMed ID: 18694404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-invasive detection of liver fibrosis in patients with chronic hepatitis C].
    Aiglová K; Ehrmann J; Ehrmann J
    Cas Lek Cesk; 2007; 146(6):542-5. PubMed ID: 17650594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3-binding protein: a serological and histological assessment in accordance with hepatitis C-related liver fibrosis.
    Cheung KJ; Libbrecht L; Tilleman K; Deforce D; Colle I; Van Vlierberghe H
    Eur J Gastroenterol Hepatol; 2010 Sep; 22(9):1066-73. PubMed ID: 20186066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative serum proteomic analysis of patients with acute-on-chronic liver failure: alpha-1-acid glycoprotein maybe a candidate marker for prognosis of hepatitis B virus infection.
    Ren F; Chen Y; Wang Y; Yan Y; Zhao J; Ding M; Zhang J; Jiang Y; Zhai Y; Duan Z
    J Viral Hepat; 2010 Nov; 17(11):816-24. PubMed ID: 20002297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis.
    Sène D; Limal N; Messous D; Ghillani-Dalbin P; Charlotte F; Thiollière JM; Piette JC; Imbert-Bismut F; Halfon P; Poynard T; Cacoub P
    Clin Biochem; 2006 Jul; 39(7):715-21. PubMed ID: 16765932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical identification and detection of serum fibronectin in liver fibrosis patients with chronic hepatitis C.
    Attallah AM; Zahran F; Ismail H; Omran MM; El-Dosoky I; Shiha GE
    J Immunoassay Immunochem; 2007; 28(4):331-42. PubMed ID: 17885887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.
    Loko MA; Castera L; Dabis F; Le Bail B; Winnock M; Coureau G; Bioulac-Sage P; de Ledinghen V; Neau D;
    Am J Gastroenterol; 2008 Aug; 103(8):1973-80. PubMed ID: 18796094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of FibroScan values for predicting hepatic fibrosis stage in patients with chronic HCV infection.
    Takemoto R; Nakamuta M; Aoyagi Y; Fujino T; Yasutake K; Koga K; Yoshimoto T; Miyahara T; Fukuizumi K; Wada Y; Takami Y; Saitsu H; Harada N; Nakashima M; Enjoji M
    J Dig Dis; 2009 May; 10(2):145-8. PubMed ID: 19426398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential analysis of associated proteome in hepatic fibrosis tissue].
    Luo XH; Yang Q; Zhang Q; Cheng ML
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3411-4. PubMed ID: 18476540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the serum proteomes of pathological stages during hepatocarcinogenesis].
    Shu H; Kang XN; Li M; Guo K; Sun L; Li S; Xie L; Deng JH; Qin X; Liu YK
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):520-5. PubMed ID: 19912687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular proteome analysis unraveled annexin A2 related to immune liver fibrosis.
    Zhang L; Peng X; Zhang Z; Feng Y; Jia X; Shi Y; Yang H; Zhang Z; Zhang X; Liu L; Yin L; Yuan Z
    J Cell Biochem; 2010 May; 110(1):219-28. PubMed ID: 20225235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C.
    Morra R; Munteanu M; Bedossa P; Dargere D; Janneau JL; Paradis V; Ratziu V; Charlotte F; Thibault V; Imbert-Bismut F; Poynard T
    Aliment Pharmacol Ther; 2007 Sep; 26(6):847-58. PubMed ID: 17767469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.
    Tumani H; Lehmensiek V; Rau D; Guttmann I; Tauscher G; Mogel H; Palm C; Hirt V; Suessmuth SD; Sapunova-Meier I; Ludolph AC; Brettschneider J
    Neurosci Lett; 2009 Mar; 452(2):214-7. PubMed ID: 19383442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of fibrosis-relevant proteins using DIGE (difference in gel electrophoresis) in different models of hepatic fibrosis.
    Henkel C; Roderfeld M; Weiskirchen R; Scheibe B; Matern S; Roeb E
    Z Gastroenterol; 2005 Jan; 43(1):23-9. PubMed ID: 15650968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum fibrinogen alpha C-chain 5.9 kDa fragment as a biomarker for early detection of hepatic fibrosis related to hepatitis C virus.
    Sogawa K; Noda K; Umemura H; Seimiya M; Kuga T; Tomonaga T; Nishimura M; Kanai F; Imazeki F; Takizawa H; Yoneda M; Nakajima A; Tsutsumi M; Yokosuka O; Nomura F
    Proteomics Clin Appl; 2013 Jun; 7(5-6):424-31. PubMed ID: 23382097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
    Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
    Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.